Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong · Delayed Price · Currency is HKD 6.00
-0.09 (-1.48%)
Feb 13, 2026, 4:08 PM HKT
HKG:1167 Revenue
Jacobio Pharmaceuticals Group had revenue of 45.66M CNY in the half year ending June 30, 2025, with 13.21% growth. This brings the company's revenue in the last twelve months to 201.37M, up 768.54% year-over-year. In the year 2024, Jacobio Pharmaceuticals Group had annual revenue of 155.71M with 145.13% growth.
Revenue (ttm)
201.37M CNY
Revenue Growth
+768.54%
P/S Ratio
21.71
Revenue / Employee
954.37K CNY
Employees
211
Market Cap
4.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155.71M | 92.19M | 145.13% |
| Dec 31, 2023 | 63.52M | -32.23M | -33.66% |
| Dec 31, 2022 | 95.75M | -57.06M | -37.34% |
| Dec 31, 2021 | 152.81M | -333.48M | -68.58% |
| Dec 31, 2020 | 486.29M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 2.01B |
| AIM Vaccine | 1.38B |
| BioDlink International Company | 1.17B |
| Shandong Boan Biotechnology | 829.27M |
| Ocumension Therapeutics | 595.79M |
| Medtide | 546.29M |
| Qyuns Therapeutics | 351.04M |
| Mirxes Holding Company | 166.32M |